[1]李春梅,李婷婷,马俊帅,等.哮喘患儿血清miRNA-185和CDC42蛋白表达变化及其对临床预后的预测价值[J].陕西医学杂志,2025,54(9):1253-1258.[doi:DOI:10.3969/j.issn.1000-7377.2025.09.018]
　LI Chunmei,LI Tingting,MA Junshuai,et al.Expression change of serum miRNA-185 and CDC42 protein in children with asthma and their predictive value for clinical prognosis[J].,2025,54(9):1253-1258.[doi:DOI:10.3969/j.issn.1000-7377.2025.09.018]
点击复制

哮喘患儿血清miRNA-185和CDC42蛋白表达变化及其对临床预后的预测价值

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年9期
页码:
1253-1258
栏目:
临床检验
出版日期:
2025-09-05

文章信息/Info

Title:
Expression change of serum miRNA-185 and CDC42 protein in children with asthma and their predictive value for clinical prognosis
作者:
李春梅1; 李婷婷2; 马俊帅3; 宋艳红1; 张艳文1; 卢艳辉1; 李文斌1; 刘振奎1; 郭卫平1
（1.河北北方学院附属第一医院儿科，河北 张家口 075000；2.张家口市妇幼保健院儿科，河北 张家口 075000；3.河北北方学院附属第一医院检验科，河北 张家口 075000）
Author(s):
LI Chunmei1; LI Tingting2; MA Junshuai3; SONG Yanhong1; ZHANG Yanwen1; LU Yanhui1; LI Wenbin1; LIU Zhenkui1; GUO Weiping1
(1.Department of Pediatrics,the First Affiliated Hospital of Hebei North University,Zhangjiakou 075000,China;2.Department of Pediatrics,Zhangjiakou Maternal and Child Health Hospital,Zhangjiakou 075000,China;3.Department of Clinical Laboratory,the First Affiliated Hospital of Hebei North University,Zhangjiakou 075000,China)
关键词:
哮喘; 微小RNA-185; 细胞分裂周期蛋白42; 血液炎症指标; 预后; 预测价值
Keywords:
Asthma; miRNA-185; Cell division cycle 42; Blood inflammatory indicators; Prognosis; Predictive value
分类号:
R 725.6
DOI:
DOI:10.3969/j.issn.1000-7377.2025.09.018
文献标志码:
A
摘要:
目的：探讨哮喘患儿血清微小RNA-185（miRNA-185）和细胞分裂周期蛋白42（CDC42）的表达变化及其对临床预后的预测价值。方法：选取哮喘患儿150例为哮喘患儿组，选取同期同年龄段体检健康儿童30例为健康对照组。采集治疗前、治疗第3个月和治疗第6个月的血清样本，检测miRNA-185和CDC42蛋白的表达情况。比较两组临床预后指标[哮喘控制测试（ACT）评分、第1秒用力呼气量占预测值的百分比（FEV1%pred）、急性发作频率、生活质量评分（PAQLQ）]及血液炎症指标。分析血清miRNA-185和CDC42蛋白与临床预后指标、血液炎症指标的相关性，以及miRNA-185和CDC42蛋白对哮喘患儿临床预后的预测价值。结果：治疗前哮喘患儿组血清miRNA-185和CDC42蛋白表达水平以及外周血嗜酸性粒细胞计数和血清总IgE水平高于健康对照组（均P<0.05）。随着治疗的进行，哮喘患儿组血清miRNA-185和CDC42蛋白表达水平以及外周血嗜酸性粒细胞计数和血清总IgE水平逐渐下降（均P<0.05）。治疗前哮喘患儿组ACT评分、FEV1%pred、PAQLQ评分低于健康对照组（均P<0.05）。随着治疗的进行，哮喘患儿组ACT评分、FEV1%pred、PAQLQ评分逐渐增加，急性发作频率逐渐降低（均P<0.05）。血清miRNA-185和CDC42蛋白与ACT评分、FEV1%pred、PAQLQ评分及呈负相关，与外周血嗜酸性粒细胞计数、急性发作频率及血清总IgE水平呈正相关（均P<0.05）。血清miRNA-185和CDC42蛋白对哮喘患儿的预后有良好的预测价值，两项联合的预测价值更高（均P<0.05）。结论：哮喘患儿血清miRNA-185和CDC42蛋白表达升高，与临床预后指标和血液炎症指标相关，对哮喘患儿的临床预后具有良好的预测价值。
Abstract:
Objective:To explore the expression changes of serum microRNA-185 (miRNA-185) and cell division cycle 42 (CDC42) protein in children with asthma and their value in predicting clinical prognosis.Methods：A total of 150 children with asthma were enrolled as the asthma group,and 30 healthy children who underwent physical examination at the same age during the same period were enrolled as the healthy control group.Serum samples were collected before treatment,3 and 6 months after treatment,and the expressions of miRNA-185 and CDC42 protein were detected.The clinical prognosis indicators Asthma Control Test (ACT) score,FEV1%pred,acute attack frequency,Pediatric Asthma Quality of Life Questionnaire (PAQLQ) score and blood inflammatory indicators were compared between the two groups.The correlation of serum miRNA-185 and CDC42 protein with clinical prognostic indicators and blood inflammatory indicators was analyzed,and the predictive value of miRNA-185 and CDC42 protein in the clinical prognosis of children with asthma was analyzed.Results:Before treatment,the asthma group had significantly higher serum miRNA-185 and CDC42 protein expression levels,peripheral blood eosinophil count and serum total IgE levels than the healthy control group (all P<0.05).With the progress of treatment,the expression levels of serum miRNA-185 and CDC42 protein,peripheral blood eosinophil count and serum total IgE levels in the asthma group gradually decreased (all P<0.05).Before treatment,the ACT score,FEV1%pred and PAQLQ score in the asthma group were lower than those in the healthy control group (all P<0.05).With the progress of treatment,the ACT score,FEV1%pred and PAQLQ score in the asthma group gradually increased,and the frequency of acute attack gradually decreased (all P<0.05).Serum miRNA-185 and CDC42 protein levels were negatively correlated with ACT score,FEV1%pred and PAQLQ score,and positively correlated with peripheral blood eosinophil count,acute attack frequency and serum total IgE level (all P<0.05).Serum miRNA-185 and CDC42 protein had good predictive value for the prognosis of children with asthma,and the combination of the two had a higher predictive value (all P<0.05).Conclusion:Children with asthma have elevated serum levels of miRNA-185 and CDC42 protein,which are associated with clinical prognostic indicators and blood inflammatory indicators.They have a good predictive value for the clinical prognosis of children with asthma.

参考文献/References:

[1]夏慧娟,付小梅,陈秋月.肺炎支原体感染诱发哮喘患儿血清中miR-424-5p和CX3CL1表达水平及与预后预测价值研究[J].现代检验医学杂志,2023,38(4)：100-104.
[2]陈亚宾,张雪丽,李宏贵,等.嗜酸粒细胞型哮喘患儿外周血单个核细胞肿瘤坏死因子α诱导蛋白8样分子2 mRNA和M2巨噬细胞检测及意义[J].陕西医学杂志,2024,53(12)：1693-1698.
[3]王秋莉,刘应科,杨晔,等.宣肺运脾方辅助西药治疗儿童哮喘并发反复呼吸道感染临床研究[J].陕西中医,2024,45(10)：1357-1360.
[4]吴华杰,贾媛媛,罗建峰,等.维生素D辅助治疗儿童支气管哮喘123例效果分析[J].空军军医大学学报,2022,43(6)：584-590.
[5]孙果,徐洋,陈雨华,等.血清嗜酸性粒细胞阳离子蛋白与白三烯B4联合预测支气管哮喘患儿预后的临床价值[J].中国现代医学杂志,2023,33(23)：16-21.
[6]郑宇,王微微,杨霄.哮喘患儿血清SFRP1、MMP12表达及其对预后的评估价值[J].临床肺科杂志,2023,28(5)：699-702.
[7]张文华,郭东梅,周锦云.微小RNA-155和γ-干扰素诱导蛋白10在咳嗽变异性哮喘患儿血清中的表达及与预后的相关性[J].中国妇幼保健,2022,37(21)：3957-3960.
[8]刘丁香.ACE及Arg16Gly基因与哮喘患儿临床预后及治疗反应的关联[J].河北医学,2022,28(7)：1099-1103.
[9]IURCHENKO N P,GLUSHCHENKO N M,NESPRYADKO S V,et al.Significance of miRNA-185-5p and miRNA-424-5p as prognostic markers in progression of early-stage endometrial cancer[J].Exp Oncol,2024,146(3)：244-252.
[10]RASTOGI D,JOHNSTON A D,NICO J,et al.Functional genomics of the pediatric obese asthma phenotype reveal enrichment of Rho-GTPase pathways[J].Am J Respir Crit Care Med,2020,202(2)：259-274.
[11]JOHANSSON K,GAGNON J D,ZHOU S K,et al.An essential role for miR-15/16 in Treg suppression and restriction of proliferation[J].Cell Rep,2023,42(10)：113298.
[12]YON C,THOMPSON D A,JUDE J A,et al.Crosstalk between CD4+ T cells and airway smooth muscle in pediatric obesity-related asthma[J].Am J Respir Crit Care Med,2023,207(4)：461-474.
[13]SONG D,YAN F,FU H,LI L,et al.A cellular census of human peripheral immune cells identifies novel cell states in lung diseases[J].Clin Transl Med,2021,11(11)：e579.
[14]ZHANG L,CHUN Y,IRIZAR H,et al.Integrated study of systemic and local airway transcriptomes in asthma reveals causal mediation of systemic effects by airway key drivers[J].Genome Med,2023,15(1)：71.
[15]WANG H,ZHANG Y,ZHONG B,et al.Cysteine and glycine-rich protein 2 retards platelet-derived growth factor-BB-evoked phenotypic transition of airway smooth muscle cells by decreasing YAP/TAZ activity[J].Cell Biochem Funct,2024,42(1)：e3896.
[16]HOCH H E,HOUIN P R,STILLWELL P C.Asthma in children：A brief review for primary care providers[J].Pediatr Ann,2019,48(3)：e103-e109.
[17]REDDEL H K,BATEMAN E D,SCHATZ M,et al.A practical guide to implementing SMART in asthma management[J].J Allergy Clin Immunol Pract,2022,10(1S)：s31-s38.
[18]FORNO E,BACHARIER L B,PHIPATANAKUL W,et al.Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels：The VDKA randomized clinical trial[J].JAMA,2020,324(8)：752-760.
[19]BIAGINI MYERS J M,SCHAUBERGER E,HE H,et al.A pediatric asthma risk score to better predict asthma development in young children[J].J Allergy Clin Immunol,2019,143(5)：1803-1810.e2.
[20]SULTAN T,SKOV F,BRUSTAD N,et al.Levels of total IgE versus specific IgE during childhood for defining and predicting T2-high asthma[J].World Allergy Organ J,2024,17(12)：100994.
[21]BACHARIER L B,MASPERO J F,KATELARIS C H,et al.Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION)：An open-label extension study[J].Lancet Respir Med,2024,12(1)：45-54.
[22]JACKSON D J,BACHARIER L B,PHIPATANAKUL W,et al.Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma[J].Ann Allergy Asthma Immunol,2023,131(1)：44-51.e4.
[23]王龙,黄燕,马磊.利多卡因对气管插管全身麻醉患儿拔管后气道恢复质量的影响[J].陕西医学杂志,2024,53(1)：86-89.
[24]BROWN A,MCNAUGHTEN B,RUSSELL C,et al.How to interpret spirometry in a child with suspected asthma[J].Arch Dis Child Educ Pract Ed,2022,107(6)：435-441.
[25]YANG J Q,KALIM K W,LI Y,et al.Rational targeting Cdc42 restrains Th2 cell differentiation and prevents allergic airway inflammation[J].Clin Exp Allergy,2019,49(1)：92-107.

相似文献/References:

[1]亢相逢,曹 玲△,崔 巍,等.哮喘患儿外周血MMP9、IFNγ及MIP1α水平变化及其与肺功能相关性研究[J].陕西医学杂志,2019,(11):1464.
　KANG Xiangfeng,CAO Ling,CUI Wei,et al.Changes of MMP9，INFγ and MIP1α in peripheral blood of asthmatic children and the correlation with lung function[J].,2019,(9):1464.
[2]陈翠仪,吴 雷,吕嘉春,等.不同严重程度老年哮喘患者降钙素基因相关肽水平临床研究[J].陕西医学杂志,2021,50(7):861.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.024]
[3]王丽萍,王恩光,张 俣.NOD 样受体热蛋白结构域相关蛋白3介导的细胞焦亡对哮喘大鼠炎症水平的调控作用[J].陕西医学杂志,2024,(4):449.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.004]
　WANG Liping,WANG Enguang,ZHANG Yu.Regulation of pyroptosis mediated by NOD-like receptor pyrin domain-related protein 3 on inflammatory in asthmatic rats[J].,2024,(9):449.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.004]
[4]施姣,肖维,周新哲.哮喘患儿血清FSTL1、ANGPTL4表达及临床意义[J].陕西医学杂志,2025,54(12):1703.[doi:DOI:10.3969/j.issn.1000-7377.2025.12.020]
　SHI Jiao,XIAO Wei,ZHOU Xinzhe.Expression and clinical significance of FSTL1 and ANGPTL4 in serum of children with asthma[J].,2025,54(9):1703.[doi:DOI:10.3969/j.issn.1000-7377.2025.12.020]

备注/Memo

备注/Memo:
河北省医学科学研究课题（20231436）
更新日期/Last Update: 2025-09-04